Maternal and Perinatal Risk Stratification in Cardiovascular Pathology. A Modern View on the Problem

Keywords: pathology of the heart and great vessels, pregnancy, cardiovascular maternal and perinatal risk stratification


Objective: to increase the safety of a patients with cardiovascular pathology during the implementation of their reproductive function, by presenting a modern strategy of medical support for such women based on the assessment of the maternal and perinatal risks.
Cardiac pathology is the leading cause of morbidity in pregnant women and an indirect cause of maternal mortality. In recent decades, the focus on the problem of safety of pregnant women with the pathology has been steadily increasing. Stratification of patients by cardiovascular risk (CVR) consists of assessing the functional capacity of the patient, cardiac medications needs, history of previous cardiac events, diagnosis of structural, anatomical, and physiological changes and parameters of heart remodeling, and, if necessary, genetic counseling. An important point is to inform the patient about the potential risks and make a consensus decision with her about the possibility of safe implementation of her reproductive function. The authors of the paper analyze the CVR assessment scales used in leading medical practices and the national health care system as well, discuss current clinical guidelines for risk stratification and registered strategies for pregnancy and delivery management depending on the class of CVR in such patients. This paper presents the basic principles of medical support for women of reproductive age with pathology of the heart and great vessels in the form of an algorithm developed by the National pregnancy heart team. Determination of the degree of risk allows to prepare a woman with cardiovascular pathology for the pregnancy and delivery (medical correction or preventive cardiac surgery). Research on the identification and categorization of maternal and perinatal CVR factors and stratification of pregnant women by risk classes are extremely relevant and continue in the framework of the international study ROPAC (Registry Of Pregnancy And Cardiac disease).
Ukrainian multidisciplinary team (on the base of two academic State Institutions – “National Amosov Institute of Cardiovascular Surgery” and “Institute of Pediatrics, Obstetrics and Gynecology named after acad. O.M. Lukianova”) takes an active part in this international collaboration.


  1. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303-11.
  2. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89(6):2673-6.
  3. Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol. 1994;23(5):1194-8.
  4. Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol. 1999;33(6):1692-5.
  5. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, Taylor DA, Gordon EP, Spears JC, Tam JW, Amankwah KS, Smallhorn JF, Farine D, Sorensen S. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-21.
  6. Сіромаха СО, Лазоришинець ВВ, Давидова ЮВ, Лиманська АЮ. Мультидисциплінарний супровід вагітних і породілей із вродженою вадою серця. Вісник серцево-судинної хірургії. 2019;(34(1)):31-7.
  7. Siromakha SO, Davydova YV, Limanska AYu, Lazoryshynets VV. [Multidisciplinary support for pregnant and parturient with congenital heart disease]. Cardiovascular Surgery Herald. 2019;(1(34)):31-7. Ukrainian.
  8. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al.; ZAHARA Investigators. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007 Jun 19;49(24):2303-11.
  9. Roberts JM, Pearson GD, Cutler JA, Lindheimer MD; National Heart Lung and Blood Institute. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy. 2003;22(2):109-27.
  10. Siromakha SO, Rusnak, AO, Davydova YV, Mazur OA, Kuchkova NP, Lazoryshynets VV. Cardiac Surgery and Obstetric Strategy for Thromboembolic Complications in Pregnant Women and Parturients. Ukrainian Journal of Cardiovascular Surgery. 2020;(1(38)):69-74.
  11. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999;353(9160):1258-65.
  12. Сіромаха СО. Орфанні спадкові захворювання грудної аорти та вагітність. Сучасні уявлення та рекомендації. Український журнал серцево-судинної хірургії. 2020;(2(39)):69-74.
  13. Siromakha SO. [Orphan Heritable Thoracic Aortic Diseases and Pregnancy. Modern Outlooks and Guidance]. Ukrainian Journal of Cardiovascular Surgery. 2020;(2(39)):69-74. Ukrainian.
  14. Elkayam U, Goland S, Pieper PG, Silverside CK. High-Risk Cardiac Disease in Pregnancy: Part I. J Am Coll Cardiol. 2016 Jul 26;68(4):396-410.
  15. Kovacs AH, Harrison JL, Colman JM, Sermer M, Siu SC, Silversides CK. Pregnancy and contraception in congenital heart disease: what women are not told. J Am Coll Cardiol. 2008;52(7):577-8.
  16. Stout K. Pregnancy in women with congenital heart disease: the importance of evaluation and counselling. Heart. 2005 Jun;91(6):713-4.
  17. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-LundqvistC,CífkováR,DeBonisM,etal.2018ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 7;39(34):3165-241.
  18. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, FoidartJ M, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011 Dec;32(24):3147-97.
  19. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006;113(4):517-24.
  20. Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, et al.; ZAHARA Investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124-32.
  21. Thorne S, Nelson-Piercy C, MacGregor A, Gibbs S, Crowhurst J, Panay N, et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care. 2006;32(2):75-81.
  22. Bianca I, Geraci G, Gulizia MM, Egidy Assenza G, Barone C, Campisi M, et al. Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases. European Heart Journal Supplements. 2017;19(Suppl D):D256-D292
  23. van Hagen IM, Roos-Hesselink JW. Pregnancy in congenital heart disease: risk prediction and counselling. Heart. 2020:heartjnl-2019-314702. Epub ahead of print.
  24. Byers PH. Vascular Ehlers-Danlos Syndrome. 1999 Sep 2 [Updated 2019 Feb 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from:
  25. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014 Nov 1;35(41):2873-926.
How to Cite
Siromakha, S. O., Davydova, Y. V., Limanska, A. Y., & Lazoryshynets, V. V. (2020). Maternal and Perinatal Risk Stratification in Cardiovascular Pathology. A Modern View on the Problem. Ukrainian Journal of Cardiovascular Surgery, (3 (40), 98-106.